Court Opinion

ID: 9326100
Source: CourtListenerOpinion
Date Created: 2022-12-14 21:00:48.573054+00
Date Added: 2024-06-11T17:15:03.011041
License: Public Domain

Case: 23-1158   Document: 5       Page: 1   Filed: 12/14/2022

          NOTE: This order is nonprecedential.

   United States Court of Appeals
       for the Federal Circuit
                 ______________________

                 TRIS PHARMA, INC.,
                   Plaintiff-Appellee

                            v.

       TEVA PHARMACEUTICALS USA, INC.,
               Defendant-Appellant
              ______________________

                       2023-1158
                 ______________________

    Appeal from the United States District Court for the
District of New Jersey in No. 2:20-cv-05212-KM-ESK,
Judge Kevin McNulty.
                ______________________

                     ON MOTION
                 ______________________

                       ORDER
    Teva Pharmaceuticals USA, Inc. moves to voluntarily
dismiss this appeal pursuant to Rule 42 of the Federal
Rules of Appellate Procedure, stating that “[n]o costs are
due” and that Tris Pharma, Inc. does not oppose the mo-
tion. Mot. at 1.
    Upon consideration thereof,
Case: 23-1158    Document: 5      Page: 2    Filed: 12/14/2022

2       TRIS PHARMA, INC.   v. TEVA PHARMACEUTICALS USA, INC.

    IT IS ORDERED THAT:
    (1) The motion is granted. The appeal is dismissed.
    (2) The parties shall bear their own costs.
                                    FOR THE COURT

December 14, 2022                   /s/ Peter R. Marksteiner
     Date                           Peter R. Marksteiner
                                    Clerk of Court

ISSUED AS A MANDATE: December 14, 2022